19 June 2013
Keywords: roche, develop, memory, candidate, swiss, drug, major
Article | 12 May 2008
Swiss drug major Roche will exercise its option to develop and commercialize US firm Memory Pharmaceuticals' drug candidate, MEM 3454, for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.